Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Public ClinicalTrials.gov record NCT02447276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the effectiveness of REGN475 compared to placebo in participants with pain due to osteoarthritis (OA) of the knee or hip and a history of inadequate joint pain relief or intolerance to current analgesic therapy.
Study identification
- NCT ID
- NCT02447276
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 421 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2015 (Type not available)
- Primary completion
- Mar 2016 (Actual)
- Completion
- Nov 2016 (Actual)
- Last update posted
- Mar 27, 2017
2015 – 2016
United States locations
- U.S. sites
- 72
- U.S. states
- 28
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Chandler | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tuscon | Arizona | — | — |
| Not listed | Hot Spring | Arkansas | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Thousand Oaks | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Walnut Creek | California | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Fleming Island | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Palm Harbor | Florida | — | — |
| Not listed | Tamarac | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Weston | Florida | — | — |
| Not listed | Winter Haven | Florida | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Frederick | Maryland | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Saint Clair Shores | Michigan | — | — |
| Not listed | Traverse City | Michigan | — | — |
| Not listed | Hattiesburg | Mississippi | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Hartsdale | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Plainview | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Jenkintown | Pennsylvania | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Jackson | Tennessee | — | — |
| Not listed | Jefferson City | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Cypress | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Mesquite | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | Waco | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Sandy City | Utah | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02447276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02447276 live on ClinicalTrials.gov.